Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Do elevated stool anti-gliadin IgA and fecal sIgA point to gluten-linked mucosal immune activation?

Elevated stool anti-gliadin IgA and fecal secretory IgA indicate an active gut mucosal immune response rather than a purely mechanical digestive problem.

PlausibleJuly 17, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

elevated stool anti-gliadin IgA and elevated fecal secretory IgA indicate gluten-linked mucosal immune activation rather than a purely mechanical digestive problem

laying out figure…
1 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim frames these stool markers as signs of localized intestinal immune activity, with anti-gliadin IgA pointing more specifically toward a gluten-related response. The mechanism described involves antigen-antibody complexing and receptor-mediated passage of gliadin across the epithelial barrier, which can expose the lamina propria to immunogenic peptides and drive mucosal activation.

Verified conclusion

Determining whether chronic gastrointestinal symptoms stem from active mucosal inflammation or mechanical dysfunction is critical for designing targeted therapeutic strategies. Fecal biomarkers offer a non-invasive look into localized intestinal immunology.

Clinical evidence and diagnostic utility

  • Specific vs. non-specific activation: Elevated stool anti-gliadin secretory IgA (sIgA) represents an antigen-specific mucosal immune response triggered directly by gluten. Conversely, total fecal sIgA is a non-specific marker of general mucosal immune activation, which can be elevated by dysbiosis, infections, or other dietary proteins.
  • Diagnostic limitations: Although these markers point to an immunological process rather than a mechanical digestive issue, they lack validation as primary diagnostic tools. Fecal anti-gliadin IgA has high specificity but very low sensitivity (6% to 10%) for celiac disease, meaning it cannot replace standard serum testing or duodenal biopsy.

Mechanistic pathways of mucosal activation

  • SIgA-gliadin complexing: In the gut lumen, elevated anti-gliadin sIgA binds to gliadin, forming stable antigen-antibody complexes.
  • CD71 retrotranscytosis: These SIgA-gliadin complexes are retrotranscytosed across the intestinal epithelial barrier, a process mediated by the transferrin receptor CD71.
  • Lamina propria delivery: This receptor-mediated pathway bypasses normal lysosomal degradation, delivering intact, immunogenic gliadin peptides directly into the lamina propria to drive localized mucosal immune activation.

Bottom line

  • Elevated stool anti-gliadin IgA and fecal sIgA indicate an active mucosal immune response rather than mechanical dysfunction, but because fecal sIgA is non-specific and fecal anti-gliadin IgA has extremely low clinical sensitivity (6% to 10%), they should be interpreted as markers of gut immune activity rather than standalone diagnostic tools for celiac disease or gluten sensitivity.

References

  1. Anti-Gliadin IgA in Stool (GI-MAP): What a High Fecal ... — healthmatters.io ↗
  2. Detection of antibodies against gliadin, endomysium and atTG in stool — wikilectures.eu ↗
  3. Anti-Gliadin sIgA, Stool - Celiac Disease, Gluten - Preventive Tests — athenslab.gr ↗
  4. GI-MAP - qPCR Stool Analysis — lamkinclinic.com ↗
  5. Secretory IgA in Stool: High & Low Levels, Normal Range ... — healthmatters.io ↗
  6. Secretory IgA (sIgA): Optimal Levels, Reference Ranges & ... — lamkinclinic.com ↗
  7. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease — rupress.org ↗
  8. Secretory IgA mediates retrotranscytosis of intact gliadin peptides ... — pmc.ncbi.nlm.nih.gov ↗
  9. Secretory IgA mediates retrotranscytosis of intact gliadin ... — pdfs.semanticscholar.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→